|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/498 | (2006.01) |
| A61K 31/498 | (2013.01) | ||
| A61K 31/7048 | (2006.01) | ||
| A61K 31/7048 | (2013.01) | ||
| A61P 17/00 | (2006.01) | ||
| A61P 17/00 | (2018.01) |
| (11) | Patento numeris | 3377063 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16798698.3 |
| Europos patento paraiškos padavimo data | 2016-11-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-09-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-08-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/078076 |
| Data | 2016-11-17 |
| (87) | Numeris | WO 2017/085226 |
| Data | 2017-05-26 |
| (30) | Numeris | Data | Šalis |
| 15306822 | 2015-11-17 | EP |
| (72) |
MARTEL, Philippe , FR
KERROUCHE, Nabil , FR
AUDIBERT, Fabien , FR
|
| (73) |
Galderma S.A. ,
Zugerstrasse 8, 6330 Cham,
CH
|
| (54) | USE OF IVERMECTIN AND BRIMONIDINE IN THE TREATMENT AND/OR PREVENTION OF MODERATE TO SEVERE ROSACEA |
| USE OF IVERMECTIN AND BRIMONIDINE IN THE TREATMENT AND/OR PREVENTION OF MODERATE TO SEVERE ROSACEA |